(Q84994355)
Statements
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure (English)
Sonja Merkesdal
Timm Kirchhoff
Diane Wolka
Gunter Ladinek
Adrian Kielhorn
Andrea Rubbert-Roth
5 December 2009